Correlation between cytokine concentrations before treatment and before the third ranibizumab injection
| R | p Value | |
| CXCL1 | 0.51 | 0.0008 |
| IP-10 | 0.64 | <0.0001 |
| CXCL12 | 0.36 | 0.0131 |
| CXCL13 | 0.49 | 0.0004 |
| MCP-1 | 0.77 | <0.0001 |
| CCL11 | 0.53 | 0.0001 |
| IL-6 | 0.54 | <0.0001 |
| IL-10 | −0.11 | 0.4759 |
| MMP-9 | 0.35 | 0.0155 |
R, correlation coefficient.
CCL11, C-C motif chemokine ligand 11; CXCL1, C-X-C motif chemokine ligand 1; CXCL12, C-X-C motif chemokine ligand 12; CXCL13, C-X-C motif chemokine ligand 13; IL-6, interleukin-6; IL-10; interleukin-10; IP-10, interferon-γ-induced protein 10; MCP-1, monocyte chemoattractant protein 1; MMP-9, matrix metalloproteinase 9.